Huldrych F. Günthard

Citée par

	Toutes	Depuis 2020
Citations	43085	12455
indice h	102	52
indice i10	380	248

2800

1400

700

2100

1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025175 267 318 284 393 418 509 531 597 668 884 1058 1467 2184 2422 2723 2718 2584 2601 2382 2355 2472 2330 2549 2549 2335 2420 230

Accès public

Tout afficher

375 articles

16 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Matthias CavassiniHead of the Infectious Diseases outpatient clinic, CHUV, Lausanne, SwitzerlandAdresse e-mail validée de chuv.ch
Roger D. KouyosUniversity of Zurich; University Hospital ZurichAdresse e-mail validée de uzh.ch
Bernard HirschelAdresse e-mail validée de hirschel.ch
Alexandra TrkolaProfessor of Medical Virology, University of ZurichAdresse e-mail validée de virology.uzh.ch
Amalio TelentiThe Scripps Research InstituteAdresse e-mail validée de scripps.edu
Herbert KusterDivision of Infectious Diseases and Hospital Epidemiology, University Hospital ZurichAdresse e-mail validée de usz.ch
Viktor von WylEpidemiology, Biostatistics & Prevention Institute; University of ZurichAdresse e-mail validée de uzh.ch
Sebastian BonhoefferTheoretical Biology, ETH ZurichAdresse e-mail validée de env.ethz.ch
Jacques FellayEPFL / CHUVAdresse e-mail validée de epfl.ch
Annette OxeniusProfessor of ImmunologyAdresse e-mail validée de micro.biol.ethz.ch
Joseph J EronProfessor of Medicine, University of North Carolina at Chapel HillAdresse e-mail validée de med.unc.edu
Deenan PillayAdresse e-mail validée de africacentre.ac.za
Roger Paredes, MD, PhDDepartment of Infectious Diseases & irsiCaixa AIDS Research Institute, Hospital Germans Trias iAdresse e-mail validée de irsicaixa.es
Robert ShaferProfessor of Medicine, Stanford UniversityAdresse e-mail validée de stanford.edu
Davey SmithProfessor of Medicine, University of California, San DiegoAdresse e-mail validée de ucsd.edu
Niko BeerenwinkelProfessor of Computational Biology, ETH ZurichAdresse e-mail validée de bsse.ethz.ch
Matthias EggerProfessor of Epidemiology & Public Health, University of BernAdresse e-mail validée de ispm.unibe.ch
paul klenermanUniversity of OxfordAdresse e-mail validée de ndm.ox.ac.uk
Francesca Di GiallonardoPostdoctoral Research Fellow, University of New South WalesAdresse e-mail validée de kirby.unsw.edu.au
Sara Gianella WeibelProfessor of Medicine, University of California San DiegoAdresse e-mail validée de ucsd.edu

Suivre

Huldrych F. Günthard

Professor for Infectious Diseases, University Hospital Zurich

Adresse e-mail validée de usz.ch - Page d'accueil

HIV-Infection treatment resistance latency transmission


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia JK Wong, M Hezareh, HF Gunthard, DV Havlir, CC Ignacio, CA Spina, ... Science 278 (5341), 1291-1295, 1997	2682	1997
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ... Gastroenterology 138 (4), 1338-1345. e7, 2010	1487	2010
2011 update of the drug resistance mutations in HIV-1 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ... Topics in antiviral medicine 19 (4), 156, 2011	1254	2011
2011 update of the drug resistance mutations in HIV-1 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ... Topics in antiviral medicine 19 (4), 156, 2011	1254	2011
Update of the drug resistance mutations in HIV-1: December 2009 VA Johnson, F Brun-Vézinet, B Clotet, HF Gunthard, DR Kuritzkes, ... Top HIV Med 17 (5), 138-145, 2009	1254*	2009
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010	1165	2010
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010	1165	2010
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ... Jama 308 (4), 387-402, 2012	1160	2012
2014 Update of the drug resistance mutations in HIV-1 AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ... Topics in antiviral medicine 22 (3), 642, 2014	1147*	2014
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ... Jama 316 (2), 191-210, 2016	907	2016
2019 update of the drug resistance mutations in HIV-1 AM Wensing, V Calvez, F Ceccherini-Silberstein, C Charpentier, ... Topics in antiviral medicine 27 (3), 111, 2019	790	2019
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ... Jama 320 (4), 379-396, 2018	734	2018
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel MS Hirsch, HF Günthard, JM Schapiro, FB Vézinet, B Clotet, SM Hammer, ... Clinical Infectious Diseases 47 (2), 266-285, 2008	679	2008
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies A Trkola, H Kuster, P Rusert, B Joos, M Fischer, C Leemann, A Manrique, ... Nature medicine 11 (6), 615-622, 2005	667	2005
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ... Jama 324 (16), 1651-1669, 2020	513	2020
Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009	483	2009
Prevalence and predictive value of intermittent viremia with combination HIV therapy DV Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, AC Collier, MS Hirsch, ... Jama 286 (2), 171-179, 2001	481	2001
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011	478	2011
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel RT Gandhi, R Bedimo, JF Hoy, RJ Landovitz, DM Smith, EF Eaton, ... Jama 329 (1), 63-84, 2023	425	2023
Cohort profile: the Swiss HIV Cohort study Swiss HIV Cohort Study, F Schoeni-Affolter, B Ledergerber, ... International journal of epidemiology 39 (5), 1179-1189, 2010	416*	2010

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs